Diseases have a molecular origin, and if we want to detect them without confusion molecular probes play a critical role.

VNIR’s novel molecular probes have unique and exceptional capabilities to diagnose diseases Alzheimer’s disease at a molecular level. So far this has not been possible, making its treatment equally difficult. VNIR is now ambitiously pursuing the path to clinical trials for these inventions.

In addition, some of VNIR’s molecular probes can play a significant role as a diagnostic support, such as for RT-PCR kit makers. We are happy to support a range of diagnostic applications using our core strengths in molecular probes.